Functional impact of PCSK9 variants on LDL uptake in a knockout hepatic model
PLOS One · 2026
DOI: 10.1371/journal.pone.0345908 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Hongmei Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center for Translation Medical Testing and Application Technology, Department of Medical Technology, Zhangzhou Health Vocati…. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Liver, Lipoproteins, LDL, Cholesterol, LDL. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhangzhou Health Vocational College.
Abstract (Originalsprache)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a central regulator of low-density lipoprotein (LDL) cholesterol metabolism, yet the functional consequences of many clinically observed PCSK9 variants remain unknown. To establish a rigorous system for quantitative variant assessment, we generated a PCSK9 knockout (KO) HepG2 cell line through CRISPR/Cas9-mediated deletion of exons 2–8, effectively removing both the prodomain and catalytic regions required for PCSK9 function. This null background enabled systematic functional mapping of wild-type (WT) PCSK9 and multiple clinically relevant variants representing well-characterized, recurrent, and previously understudied alleles. Functional assays revealed pronounced heterogeneity among variant activities. The classical gain-of-function (GOF) variants D374Y and R496W exhibited robust suppression of LDL uptake, whereas A443T—an infrequently reported and previously uncharacterized variant—demonstrated a loss-of-function (LOF)-like phenotype with significantly enhanced LDL uptake. Additional poorly characterized variants, including V4I, R104C/V114A, and R496W/N425S, displayed varied functional profiles, providing novel mechanistic insights. Surface LDL receptor (LDLR) levels generally correlated with LDL uptake but revealed unique patterns for specific variants. This KO-based rescue system provides a high-resolution framework for mechanistic classification of both established and poorly characterized PCSK9 variants, bridging the gap between genetic discovery and functional interpretation while supporting precision lipid-lowering strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Collaborative Innovation Center for Translation Medical Testing and Application Technology, Department of Medical Technology, Zhangzhou Health Vocational College, Zhangzhou, Fujian, People's Republic of China.
- Department of Basic Medicine, Zhangzhou Health Vocational College, Zhangzhou, Fujian, People's Republic of China.
- Department of Science and Technology, Zhangzhou Health Vocational College, Zhangzhou, Fujian, People's Republic of China.
ORCID-Profile: Hongmei Li
Förderung
- Zhangzhou Health Vocational College
Zitieren
APA
Li, H., Liu, H., Xu, W., Zeng, Y., Huang, P., Guo, J., Cai, B., Chen, Y., Lin, Y., & Zhang, C. (2026). Functional impact of PCSK9 variants on LDL uptake in a knockout hepatic model. PLOS One. https://doi.org/10.1371/journal.pone.0345908
Vancouver
Li H, Liu H, Xu W, Zeng Y, Huang P, Guo J, et al. Functional impact of PCSK9 variants on LDL uptake in a knockout hepatic model. PLOS One. 2026. doi:10.1371/journal.pone.0345908
BibTeX
@article{Li2026,
author = {Li, Hongmei and Liu, Huili and Xu, Wenxin and Zeng, Yuanjun and Huang, Pengfei and Guo, Jiawang and Cai, Binxiang and Chen, Yajing and Lin, Yanyan and Zhang, Chunbin},
title = {Functional impact of PCSK9 variants on LDL uptake in a knockout hepatic model},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0345908}
}
EUVIMED